Checkpoint Therapeutics buy krebskrebs
Start price
21.02.22
/
50%
€1.69
Target price
21.02.23
€2.50
Performance (%)
-70.34%
End price
22.02.23
€0.50
Summary
This prediction ended on 22.02.23 with a price of €0.50. Massive losses of -70.34% were the result for the BUY prediction by krebskrebs. krebskrebs has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Checkpoint Therapeutics | - | - | - |
iShares Core DAX® | 1.175% | -0.931% | 13.543% |
iShares Nasdaq 100 | 1.232% | 9.715% | 34.899% |
iShares Nikkei 225® | 1.563% | 3.040% | 8.943% |
iShares S&P 500 | 0.034% | 5.962% | 27.285% |
Comments by krebskrebs for this prediction
In the thread Checkpoint Therapeutics diskutieren
Buy mit Kursziel 2,5
In the thread Trading Checkpoint Therapeutics
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten